A Study to Assess the Role of Fenofibrate in Preventing Ischemic Cholangiopathy After Liver Transplantation
Status:
Recruiting
Trial end date:
2024-02-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of a once-daily
medication, fenofibrate (Lofibra), to prevent ischemic cholangiography (IC) in persons who
were transplanted with livers donated after circulatory death (DCD).